Liaoning Chengda Biotechnology Co.,Ltd.’s Net Profit Dropped 20% in 2022

Liaoning Chengda Biotechnology Co.,Ltd. (辽宁成大生物股份有限公司) (688739.SH) reported a net profit of 714 million yuan in 2022, down 20% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, down 13.1% year-on-year.

At the end of the reporting period, it had 10.1 billion yuan in total assets and 406.2 million yuan in total liabilities, with a liability-to-asset ratio of 4%.